(firstQuint)Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma.

 It has been required to develop new treatment modalities for patients with advanced heptatocellular carcinoma.

 Immunotherapy is one of the encouraging modalities for patients.

 We have to assess its toxicities, clinical response and immune responsiveness.

.

 Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma@highlight

The purpose of this study is to assess toxicities of angiogenic peptide vaccine therapy in treating HLA-A*2402 restricted patients with advanced hepatocellular carcinoma.

